首页> 外文OA文献 >MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments

【2h】

MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments

机译：MTRX1011A，一种人源化抗CD4单克隆抗体，在类风湿性关节炎患者的治疗中：I期随机，双盲，安慰剂对照研究，纳入了药效学生物标志物评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Heleen Scheerens; Zheng Su; Bryan Irving; Michael J Townsend; Yanan Zheng; Eric Stefanich; Vishala Chindalore; Clifton O Bingham; John C Davis;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments. [J] . Scheerens H, Irving B, Zheng Y, Arthritis research & therapy. . 2011,第5期

机译：MTRX1011A，一种人源化抗CD4单克隆抗体，在类风湿关节炎患者的治疗中：I期随机，双盲，安慰剂对照研究，纳入了药效学生物标志物评估。
2. MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments [J] . Heleen Scheerens, Zheng Su, Bryan Irving, Arthritis Research . 2011,第5期

机译：MTRX1011A，一种人源化抗CD4单克隆抗体，在类风湿关节炎患者的治疗中：I期随机，双盲，安慰剂对照研究，纳入了药效学生物标志物评估
3. LY2439821, a humanized anti–interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study [J] . M. C. Genovese, F. Van den Bosch, S. A. Roberson, Arthritis & Rheumatism . 2010,第4期

机译：LY2439821，一种人源化抗白介素17单克隆抗体，在类风湿关节炎患者的治疗中：I期随机，双盲，安慰剂对照，概念验证的研究
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. MTRX1011A a humanized anti-CD4 monoclonal antibody in the treatment of patients with rheumatoid arthritis: a Phase I randomized double-blind placebo-controlled study incorporating pharmacodynamic biomarker assessments [O] . Heleen Scheerens, Zheng Su, Bryan Irving, 2011

机译：MTRX1011A一种人源化抗CD4单克隆抗体在类风湿性关节炎患者的治疗中：I期随机双盲安慰剂对照研究纳入了药效学生物标志物评估
7. MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments [O] . Scheerens, Heleen, Su, Zheng, Irving, Bryan, 2011

机译：MTRX1011A，一种人源化抗CD4单克隆抗体，在类风湿性关节炎患者的治疗中：I期随机，双盲，安慰剂对照研究，纳入了药效学生物标志物评估

MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments

著录项

引文网络

相似文献

相关主题

期刊订阅